???pagination.result.count???
???pagination.result.page???
1
A convergent molecular network underlying autism and congenital heart disease. , Rosenthal SB., Cell Syst. November 17, 2021; 12 (11): 1094-1107.e6.
Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo. , Masuko T., Neurosci Lett. January 11, 2012; 506 (2): 251-5.
Amyloid β peptide oligomers directly activate NMDA receptors. , Texidó L., Cell Calcium. March 1, 2011; 49 (3): 184-90.
Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors. , Masuko T., J Pharmacol Exp Ther. November 1, 2009; 331 (2): 522-30.
CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. , Hudmon A., J Cell Biol. November 7, 2005; 171 (3): 537-47.
Alternative splicing of the NMDAR1 subunit affects modulation by calcium. , Koltchine VV., Brain Res Mol Brain Res. July 1, 1996; 39 (1-2): 99-108.
Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes. , Kuner T., Neuroreport. December 13, 1993; 5 (3): 297-300.